Rate of Heart Failure Following Atrial Fibrillation According to Presence of Family History of Dilated Cardiomyopathy or Heart Failure: A Nationwide Study.


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
16 11 2021
Historique:
pubmed: 2 11 2021
medline: 3 3 2022
entrez: 1 11 2021
Statut: ppublish

Résumé

Background It is poorly understood why some patients with atrial fibrillation develop heart failure (HF) and others do not. We examined the rate of developing HF in patients with atrial fibrillation with and without first-degree family members with HF or dilated cardiomyopathy (DCM). Methods and Results Using Danish nationwide registries, patients born after 1942 diagnosed with atrial fibrillation in the period 2005 to 2015 were identified and followed for up to 5 years. Patients with pre-existing HF, DCM, and/or ischemic heart disease diagnoses were excluded. Exposure was defined as a first-degree relative with HF or DCM. The rate of developing the composite end point of HF or death, and the components, was estimated with multivariable Cox proportional hazard regression models. We included 10 605 patients. A total of 17% had a family member with DCM/HF. Having a family member with HF/DCM was associated with an increased 5-year risk of the composite of HF/death (cumulative incidence, 9.2% [95% CI, 7.8-10.7] versus 5.6% [95% CI, 5.0-6.1]; adjusted hazard ratio [HR] 1.36 [95% CI, 1.13-1.64]). (HF 8.4% [95% CI, 7.0-9.8] versus 4.5% [95% CI, 4.1-5.0]); (adjusted HR, 1.49 [95% CI, 1.22-1.82]). However, familial HF/DCM was not significantly associated with an increased 5-year risk and rate of death (0.8% [95% CI, 0.4-1.2] versus 1.1% [95% CI, 0.8-1.3]); (adjusted HR, 0.80 [95% CI, 0.46-1.39]). Conclusions In patients with incident atrial fibrillation without prior ischemic heart disease or HF diagnoses, 1 of 6 had a first-degree relative with HF, and having such a family history of HF/DCM was associated with an 87% increase in 5-year incidence of HF compared with those without.

Identifiants

pubmed: 34719261
doi: 10.1161/JAHA.120.021286
pmc: PMC8751939
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e021286

Références

Clin Epidemiol. 2010 Oct 21;2:235-9
pubmed: 21042557
Circulation. 2016 Feb 2;133(5):484-92
pubmed: 26746177
Nat Rev Cardiol. 2016 Jun;13(6):368-78
pubmed: 26935038
Eur J Heart Fail. 2008 Jul;10(7):658-60
pubmed: 18539522
Int J Epidemiol. 2017 Jun 1;46(3):798-798f
pubmed: 27789670
JAMA. 1994 Mar 16;271(11):840-4
pubmed: 8114238
Heart Lung Circ. 2017 Sep;26(9):967-974
pubmed: 28684095
JAMA. 2004 Jul 21;292(3):344-50
pubmed: 15265849
Scand Cardiovasc J. 2012 Jun;46(3):149-53
pubmed: 22397620
Scand J Public Health. 2011 Jul;39(7 Suppl):30-3
pubmed: 21775347
JAMA. 2004 Jun 16;291(23):2851-5
pubmed: 15199036
N Engl J Med. 2002 Oct 31;347(18):1397-402
pubmed: 12409541
Nat Rev Cardiol. 2016 Mar;13(3):131-47
pubmed: 26658575
Circulation. 2003 Jun 17;107(23):2920-5
pubmed: 12771006
J Am Heart Assoc. 2016 Nov 19;5(11):
pubmed: 27866162
Clin Epidemiol. 2015 Nov 17;7:449-90
pubmed: 26604824
Eur J Epidemiol. 2014 Aug;29(8):541-9
pubmed: 24965263
Eur Heart J. 2006 Apr;27(8):949-53
pubmed: 16527828
Circulation. 2014 Feb 25;129(8):837-47
pubmed: 24345399
Circulation. 1997 Oct 7;96(7):2455-61
pubmed: 9337224
Scand J Public Health. 2011 Jul;39(7 Suppl):22-5
pubmed: 21775345
Clin Med (Lond). 2016 Jun;16(3):272-6
pubmed: 27251919
Scand J Public Health. 2011 Jul;39(7 Suppl):26-9
pubmed: 21775346
J Am Coll Cardiol. 2016 Dec 27;68(25):2871-2886
pubmed: 28007147
BMJ Open. 2016 Nov 18;6(11):e012832
pubmed: 27864249

Auteurs

Magnus N Ebbesen (MN)

Department of Cardiology, Herlev and Gentofte University Hospital Copenhagen Denmark.

Maria D'Souza (M)

Department of Cardiology, Herlev and Gentofte University Hospital Copenhagen Denmark.

Charlotte Andersson (C)

Department of Cardiology, Herlev and Gentofte University Hospital Copenhagen Denmark.
Department of Medicine Section of Cardiovascular Medicine Boston Medical Center Boston MA.

Jawad H Butt (JH)

Department of Cardiology Rigshospitalet Copenhagen Denmark.

Christian Madelaire (C)

Department of Cardiology, Herlev and Gentofte University Hospital Copenhagen Denmark.

Tor Biering-Sorensen (T)

Department of Cardiology, Herlev and Gentofte University Hospital Copenhagen Denmark.

Morten Lock-Hansen (M)

Department of Cardiology, Herlev and Gentofte University Hospital Copenhagen Denmark.

Soren Lund Kristensen (SL)

Department of Cardiology, Herlev and Gentofte University Hospital Copenhagen Denmark.

Gunnar Gislason (G)

Department of Cardiology, Herlev and Gentofte University Hospital Copenhagen Denmark.
The Danish Heart Foundation Copenhagen Denmark.
University of Copenhagen Faculty of Health and Medical Science Copenhagen Denmark.

Lars Kober (L)

Department of Cardiology Rigshospitalet Copenhagen Denmark.
University of Copenhagen Faculty of Health and Medical Science Copenhagen Denmark.

Christian Torp-Pedersen (C)

Department of Clinical Investigation and Cardiology Nordsjaellands Hospital Hillerod Denmark.

Morten Schou (M)

Department of Cardiology, Herlev and Gentofte University Hospital Copenhagen Denmark.
University of Copenhagen Faculty of Health and Medical Science Copenhagen Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH